The human clinical trials of the Oxford-AstraZeneca vaccine, which is also known as 'Covishield' in India, have been running smoothly in India and have not shown any adverse side-effects so far. The coronavirus vaccine, Covishield, is currently in Phase 2 and Phase 3 human clinical trials in the country.